{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:04:14Z","timestamp":1792605854438,"version":"4.5.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005722","name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Chronic inflammatory diseases are a significant global burden and are associated with dysregulated resolution of inflammation. Therefore, promoting the process of resolution is a promising therapeutic approach. This study presents the potent anti-inflammatory and pro-resolving effects of a natural product-derived compound called C81. Administration of C81 in a therapeutic window resolved inflammation in the murine imiquimod-induced psoriasis model, and reduced microglial infiltration in a laser-induced choroidal neovascularisation model. Investigations into the underlying mechanisms of C81 identified the DYRK1B\/STAT3 axis as a new regulator of inflammatory processes in leukocytes. The inhibition of DYRK1B by C81 resulted in attenuated STAT3 phosphorylation. The depletion of STAT3-regulated gene expression led to the inhibition of leukocyte adhesion and migration due to reduced integrin activation, and in addition to the inhibition of the release of pro-inflammatory mediators such as cytokines and eicosanoids. Importantly, the pro-resolving effects of C81 included the cell type-specific induction of apoptosis in neutrophils and a subsequent increase in efferocytosis. In conclusion, we report the DYRK1B\/STAT3 axis as a novel and promising therapeutic target for activating the resolution of inflammation.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1007\/s00018-025-05579-y","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T09:49:14Z","timestamp":1740217754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of DYRK1B BY C81 impedes inflammatory processes in leukocytes by reducing STAT3 activity"],"prefix":"10.1007","volume":"82","author":[{"given":"Sarah","family":"Ciurus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A. F.","family":"Elewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Hector","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik C.","family":"Fuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Schwalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Zech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa D.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Marschalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Langmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Bracher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9926-7578","authenticated-orcid":false,"given":"Robert","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"5579_CR1","volume-title":"Chronic inflammation","author":"R Pahwa","year":"2024","unstructured":"Pahwa R, Goyal A, Jialal I (2024) Chronic inflammation. In: StatPearls. StatPearls Publishing, Treasure Island (FL)"},{"key":"5579_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E (2022) Neutrophils in chronic inflammatory diseases. Cell Mol Immunol 19:177\u2013191. https:\/\/doi.org\/10.1038\/s41423-021-00832-3","journal-title":"Cell Mol Immunol"},{"key":"5579_CR3","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner TD, Giuliano F, Vojnovic I et al (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96:7563\u20137568. https:\/\/doi.org\/10.1073\/pnas.96.13.7563","journal-title":"Proc Natl Acad Sci USA"},{"key":"5579_CR4","first-page":"24","volume":"18","author":"ZA Marcum","year":"2010","unstructured":"Marcum ZA, Hanlon JT (2010) Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care 18:24\u201327","journal-title":"Ann Longterm Care"},{"key":"5579_CR5","doi-asserted-by":"publisher","unstructured":"Arango Duque G, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. https:\/\/doi.org\/10.3389\/fimmu.2014.00491. Front Immunol 5:","DOI":"10.3389\/fimmu.2014.00491"},{"key":"5579_CR6","first-page":"465","volume":"85","author":"ER Unanue","year":"1976","unstructured":"Unanue ER, Beller DI, Calderon J et al (1976) Regulation of immunity and inflammation by mediators from macrophages. Am J Pathol 85:465\u2013478","journal-title":"Am J Pathol"},{"key":"5579_CR7","doi-asserted-by":"publisher","first-page":"31065","DOI":"10.1074\/jbc.272.49.31065","volume":"272","author":"T Fournier","year":"1997","unstructured":"Fournier T, Fadok V, Henson PM (1997) Tumor necrosis Factor-\u03b1 inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. J Biol Chem 272:31065\u201331072. https:\/\/doi.org\/10.1074\/jbc.272.49.31065","journal-title":"J Biol Chem"},{"key":"5579_CR8","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.4049\/jimmunol.160.6.2974","volume":"160","author":"H Naraba","year":"1998","unstructured":"Naraba H, Murakami M, Matsumoto H et al (1998) Segregated coupling of phospholipases A2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J Immunol 160:2974\u20132982","journal-title":"J Immunol"},{"key":"5579_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1006\/abbi.2001.2614","volume":"397","author":"M Lazarus","year":"2002","unstructured":"Lazarus M, Kubata BK, Eguchi N et al (2002) Biochemical characterization of mouse microsomal prostaglandin E Synthase-1 and its colocalization with Cyclooxygenase-2 in peritoneal macrophages. Arch Biochem Biophys 397:336\u2013341. https:\/\/doi.org\/10.1006\/abbi.2001.2614","journal-title":"Arch Biochem Biophys"},{"key":"5579_CR10","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nri2156","volume":"7","author":"K Ley","year":"2007","unstructured":"Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678\u2013689. https:\/\/doi.org\/10.1038\/nri2156","journal-title":"Nat Rev Immunol"},{"key":"5579_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000284367","volume":"2","author":"S Fox","year":"2010","unstructured":"Fox S, Leitch AE, Duffin R et al (2010) Neutrophil apoptosis: relevance to the Innate Immune Response and Inflammatory Disease. J Innate Immun 2:216\u2013227. https:\/\/doi.org\/10.1159\/000284367","journal-title":"J Innate Immun"},{"key":"5579_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/clinids\/10.1.223","volume":"10","author":"II Mechnikov","year":"1988","unstructured":"Mechnikov II (1988) Immunity in Infective diseases. Clin Infect Dis 10:223\u2013227. https:\/\/doi.org\/10.1093\/clinids\/10.1.223","journal-title":"Clin Infect Dis"},{"key":"5579_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20:200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"key":"5579_CR14","doi-asserted-by":"publisher","unstructured":"Krishnathas GM, Str\u00f6dke B, Mittmann L et al (2021) C81-evoked inhibition of the TNFR1\u2010NF\u03baB pathway during inflammatory processes for stabilization of the impaired vascular endothelial barrier for leukocytes. FASEB J 35. https:\/\/doi.org\/10.1096\/fj.202100037R","DOI":"10.1096\/fj.202100037R"},{"key":"5579_CR15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1055\/s-0030-1250406","volume":"77","author":"J Rej\u00f3n-Orantes","year":"2011","unstructured":"Rej\u00f3n-Orantes J, Gonz\u00e1lez-Esquinca A, De La Mora M et al (2011) Annomontine, an Alkaloid isolated from Annona purpurea, has Anxiolytic-Like effects in the elevated plus-maze. Planta Med 77:322\u2013327. https:\/\/doi.org\/10.1055\/s-0030-1250406","journal-title":"Planta Med"},{"key":"5579_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/ardp.201400328","volume":"348","author":"B Str\u00f6dke","year":"2015","unstructured":"Str\u00f6dke B, Gehring AP, Bracher F (2015) Synthesis of desaza analogues of annomontine and canthin-4-one alkaloids. Arch Pharm (Weinheim) 348:125\u2013131. https:\/\/doi.org\/10.1002\/ardp.201400328","journal-title":"Arch Pharm (Weinheim)"},{"key":"5579_CR17","doi-asserted-by":"publisher","unstructured":"Zech T, Wolf A, Hector M et al (2024) 2-Desaza-annomontine (C81) impedes angiogenesis through reduced VEGFR2 expression derived from inhibition of CDC2-like kinases. https:\/\/doi.org\/10.1007\/s10456-024-09906-y. Angiogenesis","DOI":"10.1007\/s10456-024-09906-y"},{"key":"5579_CR18","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R et al (2002) The protein kinase complement of the Human Genome. Science 298:1912\u20131934. https:\/\/doi.org\/10.1126\/science.1075762","journal-title":"Science"},{"key":"5579_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2010.11.009","volume":"18","author":"O Fedorov","year":"2011","unstructured":"Fedorov O, Huber K, Eisenreich A et al (2011) Specific CLK inhibitors from a Novel Chemotype for Regulation of Alternative Splicing. Chem Biol 18:67\u201376. https:\/\/doi.org\/10.1016\/j.chembiol.2010.11.009","journal-title":"Chem Biol"},{"key":"5579_CR20","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.3390\/ijms22116047","volume":"22","author":"MF Lindberg","year":"2021","unstructured":"Lindberg MF, Meijer L (2021) Dual-Specificity, tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an overview. IJMS 22:6047. https:\/\/doi.org\/10.3390\/ijms22116047","journal-title":"IJMS"},{"key":"5579_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1096\/fj.10-165837","volume":"25","author":"S Aranda","year":"2011","unstructured":"Aranda S, Laguna A, Luna SDL (2011) DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB j 25:449\u2013462. https:\/\/doi.org\/10.1096\/fj.10-165837","journal-title":"FASEB j"},{"key":"5579_CR22","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.4161\/cc.21404","volume":"11","author":"W Becker","year":"2012","unstructured":"Becker W (2012) Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control. Cell Cycle 11:3389\u20133394. https:\/\/doi.org\/10.4161\/cc.21404","journal-title":"Cell Cycle"},{"key":"5579_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1385\/CBB:45:3:303","volume":"45","author":"SE Mercer","year":"2006","unstructured":"Mercer SE, Friedman E (2006) Mirk\/Dyrk1B: a multifunctional dual-specificity kinase involved in growth arrest, differentiation, and cell survival. CBB 45:303\u2013315. https:\/\/doi.org\/10.1385\/CBB:45:3:303","journal-title":"CBB"},{"key":"5579_CR24","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van Der Fits","year":"2009","unstructured":"Van Der Fits L, Mourits S, Voerman JSA et al (2009) Imiquimod-Induced Psoriasis-Like skin inflammation in mice is mediated via the IL-23\/IL-17 Axis. J Immunol 182:5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999","journal-title":"J Immunol"},{"key":"5579_CR25","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1038\/s41467-020-16400-8","volume":"11","author":"A Wolf","year":"2020","unstructured":"Wolf A, Herb M, Schramm M, Langmann T (2020) The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye. Nat Commun 11:2709. https:\/\/doi.org\/10.1038\/s41467-020-16400-8","journal-title":"Nat Commun"},{"key":"5579_CR26","first-page":"4414","volume":"51","author":"HJ Kaplan","year":"2010","unstructured":"Kaplan HJ, Chiang C-W, Chen J, Song S-K (2010) Vitreous volume of the mouse measured by quantitative high-resolution MRI. Investig Ophthalmol Vis Sci 51:4414\u20134414","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"5579_CR27","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIA. J Clin Invest 52:2745\u20132756. https:\/\/doi.org\/10.1172\/JCI107470","journal-title":"J Clin Invest"},{"key":"5579_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","volume":"139","author":"I Nicoletti","year":"1991","unstructured":"Nicoletti I, Migliorati G, Pagliacci MC et al (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271\u2013279. https:\/\/doi.org\/10.1016\/0022-1759(91)90198-O","journal-title":"J Immunol Methods"},{"key":"5579_CR29","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.chembiol.2023.06.002","volume":"30","author":"MP Schwalm","year":"2023","unstructured":"Schwalm MP, Kr\u00e4mer A, D\u00f6lle A et al (2023) Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization. Cell Chem Biol 30:753\u2013765e8. https:\/\/doi.org\/10.1016\/j.chembiol.2023.06.002","journal-title":"Cell Chem Biol"},{"key":"5579_CR30","doi-asserted-by":"publisher","unstructured":"Primke P TF, I R, Elewa MAF et al (2023) The Microtubule-Targeting Agent Pretubulysin impairs the inflammatory response in endothelial cells by a JNK-Dependent deregulation of the histone acetyltransferase Brd4. Cells 12:2112. https:\/\/doi.org\/10.3390\/cells12162112","DOI":"10.3390\/cells12162112"},{"key":"5579_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1432-1033.1997.00215.x","volume":"245","author":"CG Gahmberg","year":"1997","unstructured":"Gahmberg CG, Tolvanen M, Kotovuori P (1997) Leukocyte adhesion: structure and function of human leukocyte \u03b2 2 -Integrins and their Cellular Ligands. Eur J Biochem 245:215\u2013232. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.00215.x","journal-title":"Eur J Biochem"},{"key":"5579_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pharmthera.2014.11.008","volume":"147","author":"I Mitroulis","year":"2015","unstructured":"Mitroulis I, Alexaki VI, Kourtzelis I et al (2015) Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol Ther 147:123\u2013135. https:\/\/doi.org\/10.1016\/j.pharmthera.2014.11.008","journal-title":"Pharmacol Ther"},{"key":"5579_CR33","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1128\/MCB.20.6.1956-1969.2000","volume":"20","author":"K Katagiri","year":"2000","unstructured":"Katagiri K, Hattori M, Minato N et al (2000) Rap1 is a potent activation signal for leukocyte function-Associated Antigen 1 distinct from Protein Kinase C and phosphatidylinositol-3-OH kinase. Mol Cell Biol 20:1956\u20131969. https:\/\/doi.org\/10.1128\/MCB.20.6.1956-1969.2000","journal-title":"Mol Cell Biol"},{"key":"5579_CR34","doi-asserted-by":"publisher","first-page":"e30404","DOI":"10.1371\/journal.pone.0030404","volume":"7","author":"L Yi","year":"2012","unstructured":"Yi L, Chandrasekaran P, Venkatesan S (2012) TLR Signaling paralyzes Monocyte Chemotaxis through Synergized effects of p38 MAPK and global Rap-1 activation. PLoS ONE 7:e30404. https:\/\/doi.org\/10.1371\/journal.pone.0030404","journal-title":"PLoS ONE"},{"key":"5579_CR35","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1128\/MCB.21.2.438-448.2001","volume":"21","author":"A Schmidt","year":"2001","unstructured":"Schmidt A, Caron E, Hall A (2001) Lipopolysaccharide-Induced activation of \u03b22-Integrin function in Macrophages requires irak kinase activity, p38 mitogen- activated protein kinase, and the Rap1 GTPase. Mol Cell Biol 21:438\u2013448. https:\/\/doi.org\/10.1128\/MCB.21.2.438-448.2001","journal-title":"Mol Cell Biol"},{"key":"5579_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1083\/jcb.200301133","volume":"161","author":"M Shimonaka","year":"2003","unstructured":"Shimonaka M, Katagiri K, Nakayama T et al (2003) Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol 161:417\u2013427. https:\/\/doi.org\/10.1083\/jcb.200301133","journal-title":"J Cell Biol"},{"key":"5579_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1182\/blood-2009-03-211979","volume":"115","author":"Y Ebisuno","year":"2010","unstructured":"Ebisuno Y, Katagiri K, Katakai T et al (2010) Rap1 controls lymphocyte adhesion cascade and interstitial migration within lymph nodes in RAPL-dependent and -independent manners. Blood 115:804\u2013814. https:\/\/doi.org\/10.1182\/blood-2009-03-211979","journal-title":"Blood"},{"key":"5579_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ceb.2009.06.004","volume":"21","author":"B Boettner","year":"2009","unstructured":"Boettner B, Van Aelst L (2009) Control of cell adhesion dynamics by Rap1 signaling. Curr Opin Cell Biol 21:684\u2013693. https:\/\/doi.org\/10.1016\/j.ceb.2009.06.004","journal-title":"Curr Opin Cell Biol"},{"key":"5579_CR39","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1189\/jlb.0506357","volume":"80","author":"MJ Lorenowicz","year":"2006","unstructured":"Lorenowicz MJ, Van Gils J, De Boer M et al (2006) Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis. J Leukoc Biol 80:1542\u20131552. https:\/\/doi.org\/10.1189\/jlb.0506357","journal-title":"J Leukoc Biol"},{"key":"5579_CR40","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s10753-022-01699-w","volume":"45","author":"C Ju","year":"2022","unstructured":"Ju C, Wang Y, Zang C et al (2022) Inhibition of Dyrk1A attenuates LPS-Induced Neuroinflammation via the TLR4\/NF-\u03baB P65 Signaling Pathway. Inflammation 45:2375\u20132387. https:\/\/doi.org\/10.1007\/s10753-022-01699-w","journal-title":"Inflammation"},{"key":"5579_CR41","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1021\/acs.jmedchem.5b00098","volume":"58","author":"JG Kettle","year":"2015","unstructured":"Kettle JG, Ballard P, Bardelle C et al (2015) Discovery and optimization of a Novel Series of Dyrk1B kinase inhibitors to explore a MEK Resistance Hypothesis. J Med Chem 58:2834\u20132844. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00098","journal-title":"J Med Chem"},{"key":"5579_CR42","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang L, Jia K, Chen C et al (2022) DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation 145:829\u2013846. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.055727","journal-title":"Circulation"},{"key":"5579_CR43","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.chembiol.2006.11.001","volume":"13","author":"JS McMurray","year":"2006","unstructured":"McMurray JS (2006) A New Small-Molecule Stat3 inhibitor. Chem Biol 13:1123\u20131124. https:\/\/doi.org\/10.1016\/j.chembiol.2006.11.001","journal-title":"Chem Biol"},{"key":"5579_CR44","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1182\/blood-2006-03-013771","volume":"109","author":"I Dzhagalov","year":"2007","unstructured":"Dzhagalov I, St. John A, He Y-W (2007) The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood 109:1620\u20131626. https:\/\/doi.org\/10.1182\/blood-2006-03-013771","journal-title":"Blood"},{"key":"5579_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20030407","volume":"374","author":"PC Heinrich","year":"2003","unstructured":"Heinrich PC, Behrmann I, Haan S et al (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1\u201320. https:\/\/doi.org\/10.1042\/bj20030407","journal-title":"Biochem J"},{"key":"5579_CR46","doi-asserted-by":"publisher","first-page":"29468","DOI":"10.1074\/jbc.M204990200","volume":"277","author":"KMT De Bruyn","year":"2002","unstructured":"De Bruyn KMT, Rangarajan S, Reedquist KA et al (2002) The small GTPase Rap1 is required for Mn2+- and antibody-induced LFA-1- and VLA-4-mediated cell adhesion. J Biol Chem 277:29468\u201329476. https:\/\/doi.org\/10.1074\/jbc.M204990200","journal-title":"J Biol Chem"},{"key":"5579_CR47","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1128\/MCB.01227-12","volume":"33","author":"J Yan","year":"2013","unstructured":"Yan J, Mei FC, Cheng H et al (2013) Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol Cell Biol 33:918\u2013926. https:\/\/doi.org\/10.1128\/MCB.01227-12","journal-title":"Mol Cell Biol"},{"key":"5579_CR48","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1128\/MCB.00207-06","volume":"26","author":"WA Sands","year":"2006","unstructured":"Sands WA, Woolson HD, Milne GR et al (2006) Exchange protein activated by cyclic AMP (Epac)-Mediated induction of suppressor of Cytokine Signaling 3 (SOCS-3) in vascular endothelial cells. Mol Cell Biol 26:6333\u20136346. https:\/\/doi.org\/10.1128\/MCB.00207-06","journal-title":"Mol Cell Biol"},{"key":"5579_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1042\/BJ20140952","volume":"465","author":"M Almahariq","year":"2015","unstructured":"Almahariq M, Mei FC, Wang H et al (2015) Exchange protein directly activated by cAMP modulates regulatory T-cell-mediated immunosuppression. Biochem J 465:295\u2013303. https:\/\/doi.org\/10.1042\/BJ20140952","journal-title":"Biochem J"},{"key":"5579_CR50","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.molimm.2009.02.018","volume":"46","author":"L Samavati","year":"2009","unstructured":"Samavati L, Rastogi R, Du W et al (2009) STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol 46:1867\u20131877. https:\/\/doi.org\/10.1016\/j.molimm.2009.02.018","journal-title":"Mol Immunol"},{"key":"5579_CR51","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2018.8542","author":"X Liu","year":"2018","unstructured":"Liu X, Yin S, Chen Y et al (2018) LPS\u2013induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF\u2013\u03baB, STAT3 or AP\u20131 activation. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2018.8542","journal-title":"Mol Med Rep"},{"key":"5579_CR52","doi-asserted-by":"publisher","first-page":"e23173","DOI":"10.1096\/fj.202201982RRR","volume":"37","author":"Y Shao","year":"2023","unstructured":"Shao Y, Lan Y, Chai X et al (2023) CXCL8 induces M2 macrophage polarization and inhibits CD8 + T cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer. FASEB J 37:e23173. https:\/\/doi.org\/10.1096\/fj.202201982RRR","journal-title":"FASEB J"},{"key":"5579_CR53","doi-asserted-by":"publisher","first-page":"e00332","DOI":"10.1128\/MCB.00332-18","volume":"39","author":"HH Al-Khalaf","year":"2019","unstructured":"Al-Khalaf HH, Al-Harbi B, Al-Sayed A et al (2019) Interleukin-8 activates breast Cancer-Associated adipocytes and promotes their angiogenesis- and tumorigenesis-promoting effects. Mol Cell Biol 39:e00332\u2013e00318. https:\/\/doi.org\/10.1128\/MCB.00332-18","journal-title":"Mol Cell Biol"},{"key":"5579_CR54","doi-asserted-by":"publisher","first-page":"5870","DOI":"10.1523\/JNEUROSCI.5385-07.2008","volume":"28","author":"N De La Iglesia","year":"2008","unstructured":"De La Iglesia N, Konopka G, Lim K-L et al (2008) Deregulation of a STAT3-Interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci 28:5870\u20135878. https:\/\/doi.org\/10.1523\/JNEUROSCI.5385-07.2008","journal-title":"J Neurosci"},{"key":"5579_CR55","doi-asserted-by":"publisher","first-page":"723846","DOI":"10.3389\/fmolb.2022.723846","volume":"9","author":"X Xiong","year":"2022","unstructured":"Xiong X, Liao X, Qiu S et al (2022) CXCL8 in Tumor Biology and its implications for clinical translation. Front Mol Biosci 9:723846. https:\/\/doi.org\/10.3389\/fmolb.2022.723846","journal-title":"Front Mol Biosci"},{"key":"5579_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3390\/ijms20010098","volume":"20","author":"T Zheng","year":"2018","unstructured":"Zheng T, Ma G, Tang M et al (2018) IL-8 secreted from M2 macrophages promoted prostate tumorigenesis via STAT3\/MALAT1 pathway. IJMS 20:98. https:\/\/doi.org\/10.3390\/ijms20010098","journal-title":"IJMS"},{"key":"5579_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23\u201335. https:\/\/doi.org\/10.1038\/nri978","journal-title":"Nat Rev Immunol"},{"key":"5579_CR58","doi-asserted-by":"publisher","first-page":"118995","DOI":"10.1016\/j.bbamcr.2021.118995","volume":"1868","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Mohamed HT, El-Husseiny N et al (2021) IL-8 secreted by tumor associated macrophages contribute to lapatinib resistance in HER2-positive locally advanced breast cancer via activation of Src\/STAT3\/ERK1\/2-mediated EGFR signaling. Biochimica et Biophysica Acta (BBA) -. Mol Cell Res 1868:118995. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.118995","journal-title":"Mol Cell Res"},{"key":"5579_CR59","first-page":"729","volume":"9","author":"JJW Chen","year":"2003","unstructured":"Chen JJW, Yao P-L, Yuan A et al (2003) Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clin Cancer Res 9:729\u2013737","journal-title":"Clin Cancer Res"},{"key":"5579_CR60","doi-asserted-by":"publisher","first-page":"e000308","DOI":"10.1136\/jitc-2019-000308","volume":"8","author":"M Zhang","year":"2020","unstructured":"Zhang M, Huang L, Ding G et al (2020) Interferon gamma inhibits CXCL8\u2013CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. J Immunother Cancer 8:e000308. https:\/\/doi.org\/10.1136\/jitc-2019-000308","journal-title":"J Immunother Cancer"},{"key":"5579_CR61","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-7","volume":"161","author":"EA Dennis","year":"2000","unstructured":"Dennis EA (2000) Phospholipase A 2 in Eicosanoid Generation. Am J Respir Crit Care Med 161:S32\u2013S35. https:\/\/doi.org\/10.1164\/ajrccm.161.supplement_1.ltta-7","journal-title":"Am J Respir Crit Care Med"},{"key":"5579_CR62","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3390\/biom10101402","volume":"10","author":"FJ Ashcroft","year":"2020","unstructured":"Ashcroft FJ, Mahammad N, Midtun Flatekv\u00e5l H et al (2020) cPLA2\u03b1 enzyme inhibition attenuates inflammation and keratinocyte proliferation. Biomolecules 10:1402. https:\/\/doi.org\/10.3390\/biom10101402","journal-title":"Biomolecules"},{"key":"5579_CR63","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/j.1476-5381.2012.02114.x","volume":"167","author":"A Huwiler","year":"2012","unstructured":"Huwiler A, Feuerherm AJ, Sakem B et al (2012) The \u03c93-polyunsaturated fatty acid derivatives AVX 001 and AVX 002 directly inhibit cytosolic phospholipase a 2 and suppress PGE 2 formation in mesangial cells. Br J Pharmacol 167:1691\u20131701. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02114.x","journal-title":"Br J Pharmacol"},{"key":"5579_CR64","doi-asserted-by":"publisher","first-page":"e0119088","DOI":"10.1371\/journal.pone.0119088","volume":"10","author":"RM Sommerfelt","year":"2015","unstructured":"Sommerfelt RM, Feuerherm AJ, Skuland T, Johansen B (2015) Cytosolic phospholipase A2 modulates TLR2 signaling in Synoviocytes. PLoS ONE 10:e0119088. https:\/\/doi.org\/10.1371\/journal.pone.0119088","journal-title":"PLoS ONE"},{"key":"5579_CR65","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/jdv.14128","volume":"31","author":"SH Omland","year":"2017","unstructured":"Omland SH, Habicht A, Damsbo P et al (2017) A randomized, double-blind, placebo\u2010controlled, dose\u2010escalation first\u2010in\u2010man study (phase 0) to assess the safety and efficacy of topical cytosolic phospholipase A2 inhibitor, AVX 001, in patients with mild to moderate plaque psoriasis. Acad Dermatol Venereol 31:1161\u20131167. https:\/\/doi.org\/10.1111\/jdv.14128","journal-title":"Acad Dermatol Venereol"},{"key":"5579_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13075-018-1794-6","volume":"21","author":"AJ Feuerherm","year":"2019","unstructured":"Feuerherm AJ, Dennis EA, Johansen B (2019) Cytosolic group IVA phospholipase A2 inhibitors, AVX001 and AVX002, ameliorate collagen-induced arthritis. Arthritis Res Ther 21:29. https:\/\/doi.org\/10.1186\/s13075-018-1794-6","journal-title":"Arthritis Res Ther"},{"key":"5579_CR67","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1021\/cr200085w","volume":"111","author":"EA Dennis","year":"2011","unstructured":"Dennis EA, Cao J, Hsu Y-H et al (2011) Phospholipase A 2 enzymes: physical structure, biological function, Disease Implication, Chemical Inhibition, and therapeutic intervention. Chem Rev 111:6130\u20136185. https:\/\/doi.org\/10.1021\/cr200085w","journal-title":"Chem Rev"},{"key":"5579_CR68","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbalip.2016.06.004","volume":"1861","author":"L Pe\u00f1a","year":"2016","unstructured":"Pe\u00f1a L, Meana C, Astudillo AM et al (2016) Critical role for cytosolic group IVA phospholipase A2 in early adipocyte differentiation and obesity. Biochimica et Biophysica Acta (BBA) - molecular and cell. Biology Lipids 1861:1083\u20131095. https:\/\/doi.org\/10.1016\/j.bbalip.2016.06.004","journal-title":"Biology Lipids"},{"key":"5579_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.7150\/ijms.24068","volume":"16","author":"C-C Chang","year":"2019","unstructured":"Chang C-C, Sia K-C, Chang J-F et al (2019) Lipopolysaccharide promoted proliferation and adipogenesis of preadipocytes through JAK\/STAT and AMPK-regulated cPLA2 expression. Int J Med Sci 16:167\u2013179. https:\/\/doi.org\/10.7150\/ijms.24068","journal-title":"Int J Med Sci"},{"key":"5579_CR70","doi-asserted-by":"publisher","first-page":"821","DOI":"10.18433\/J3VW2F","volume":"16","author":"S Harirforoosh","year":"2014","unstructured":"Harirforoosh S, Asghar W, Jamali F (2014) Adverse effects of nonsteroidal antiinflammatory drugs: an update of Gastrointestinal, Cardiovascular and Renal complications. J Pharm Pharm Sci 16:821. https:\/\/doi.org\/10.18433\/J3VW2F","journal-title":"J Pharm Pharm Sci"},{"key":"5579_CR71","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","volume":"24","author":"C Sostres","year":"2010","unstructured":"Sostres C, Gargallo CJ, Arroyo MT, Lanas A (2010) Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol 24:121\u2013132. https:\/\/doi.org\/10.1016\/j.bpg.2009.11.005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5579_CR72","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.prostaglandins.2013.09.001","volume":"107","author":"P Leclerc","year":"2013","unstructured":"Leclerc P, Idborg H, Spahiu L et al (2013) Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation. Prostaglandins Other Lipid Mediat 107:26\u201334. https:\/\/doi.org\/10.1016\/j.prostaglandins.2013.09.001","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"5579_CR73","doi-asserted-by":"publisher","first-page":"4625","DOI":"10.1111\/bph.14827","volume":"176","author":"K Larsson","year":"2019","unstructured":"Larsson K, Steinmetz J, Bergqvist F et al (2019) Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone. Br J Pharmacol 176:4625\u20134638. https:\/\/doi.org\/10.1111\/bph.14827","journal-title":"Br J Pharmacol"},{"key":"5579_CR74","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1111\/bph.13939","volume":"174","author":"G Ozen","year":"2017","unstructured":"Ozen G, Gomez I, Daci A et al (2017) I nhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI 2: a safer alternative to COX\u20102 inhibition. Br J Pharmacol 174:4087\u20134098. https:\/\/doi.org\/10.1111\/bph.13939","journal-title":"Br J Pharmacol"},{"key":"5579_CR75","doi-asserted-by":"publisher","first-page":"100310","DOI":"10.1016\/j.jlr.2022.100310","volume":"63","author":"J Steinmetz-Sp\u00e4h","year":"2022","unstructured":"Steinmetz-Sp\u00e4h J, Liu J, Singh R et al (2022) Biosynthesis of prostaglandin 15dPGJ2 -glutathione and 15dPGJ2-cysteine conjugates in macrophages and mast cells via MGST3. J Lipid Res 63:100310. https:\/\/doi.org\/10.1016\/j.jlr.2022.100310","journal-title":"J Lipid Res"},{"key":"5579_CR76","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.21037\/tcr-21-2834","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Qiu M, Li B et al (2022) Growth of T-cell lymphoma cells is inhibited by mPGES-1\/PGE2 suppression via JAK\/STAT, TGF-\u03b2\/Smad3 and PI3K\/AKT signal pathways. Transl Cancer Res TCR 11:2175\u20132184. https:\/\/doi.org\/10.21037\/tcr-21-2834","journal-title":"Transl Cancer Res TCR"},{"key":"5579_CR77","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s10495-017-1418-7","volume":"22","author":"J Yu","year":"2017","unstructured":"Yu J, Wu Y, Wang L et al (2017) mPGES-1-derived prostaglandin E2 stimulates Stat3 to promote podocyte apoptosis. Apoptosis 22:1431\u20131440. https:\/\/doi.org\/10.1007\/s10495-017-1418-7","journal-title":"Apoptosis"},{"key":"5579_CR78","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.brainresbull.2011.09.006","volume":"86","author":"C Rummel","year":"2011","unstructured":"Rummel C, Matsumura K, Luheshi GN (2011) Circulating IL-6 contributes to peripheral LPS-induced mPGES-1 expression in the rat brain. Brain Res Bull 86:319\u2013325. https:\/\/doi.org\/10.1016\/j.brainresbull.2011.09.006","journal-title":"Brain Res Bull"},{"key":"5579_CR79","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ni.2921","volume":"15","author":"WM Nauseef","year":"2014","unstructured":"Nauseef WM, Borregaard N (2014) Neutrophils at work. Nat Immunol 15:602\u2013611. https:\/\/doi.org\/10.1038\/ni.2921","journal-title":"Nat Immunol"},{"key":"5579_CR80","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"A Mantovani","year":"2011","unstructured":"Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11:519\u2013531. https:\/\/doi.org\/10.1038\/nri3024","journal-title":"Nat Rev Immunol"},{"key":"5579_CR81","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.immuni.2016.02.026","volume":"44","author":"S Gordon","year":"2016","unstructured":"Gordon S (2016) Phagocytosis: an immunobiologic process. Immunity 44:463\u2013475. https:\/\/doi.org\/10.1016\/j.immuni.2016.02.026","journal-title":"Immunity"},{"key":"5579_CR82","doi-asserted-by":"publisher","first-page":"866747","DOI":"10.3389\/fimmu.2022.866747","volume":"13","author":"JG Filep","year":"2022","unstructured":"Filep JG (2022) Targeting neutrophils for promoting the resolution of inflammation. Front Immunol 13:866747. https:\/\/doi.org\/10.3389\/fimmu.2022.866747","journal-title":"Front Immunol"},{"key":"5579_CR83","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A (2010) Nonresolving inflammation. Cell 140:871\u2013882. https:\/\/doi.org\/10.1016\/j.cell.2010.02.029","journal-title":"Cell"},{"key":"5579_CR84","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nm1468","volume":"12","author":"AG Rossi","year":"2006","unstructured":"Rossi AG, Sawatzky DA, Walker A et al (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12:1056\u20131064. https:\/\/doi.org\/10.1038\/nm1468","journal-title":"Nat Med"},{"key":"5579_CR85","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1164\/rccm.200810-1601OC","volume":"180","author":"D El Kebir","year":"2009","unstructured":"El Kebir D, J\u00f3zsef L, Pan W et al (2009) 15-Epi-lipoxin A 4 inhibits Myeloperoxidase Signaling and enhances resolution of Acute Lung Injury. Am J Respir Crit Care Med 180:311\u2013319. https:\/\/doi.org\/10.1164\/rccm.200810-1601OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5579_CR86","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1038\/s41467-019-10903-9","volume":"10","author":"S Kumaran Satyanarayanan","year":"2019","unstructured":"Kumaran Satyanarayanan S, El Kebir D, Soboh S et al (2019) IFN-\u03b2 is a macrophage-derived effector cytokine facilitating the resolution of bacterial inflammation. Nat Commun 10:3471. https:\/\/doi.org\/10.1038\/s41467-019-10903-9","journal-title":"Nat Commun"},{"key":"5579_CR87","doi-asserted-by":"publisher","first-page":"36980","DOI":"10.1038\/srep36980","volume":"6","author":"LJ Hoodless","year":"2016","unstructured":"Hoodless LJ, Lucas CD, Duffin R et al (2016) Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo. Sci Rep 6:36980. https:\/\/doi.org\/10.1038\/srep36980","journal-title":"Sci Rep"},{"key":"5579_CR88","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/hep.20966","volume":"42","author":"H Isomoto","year":"2005","unstructured":"Isomoto H, Kobayashi S, Werneburg NW et al (2005) Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells. Hepatology 42:1329\u20131338. https:\/\/doi.org\/10.1002\/hep.20966","journal-title":"Hepatology"},{"key":"5579_CR89","doi-asserted-by":"publisher","first-page":"7486","DOI":"10.4049\/jimmunol.166.12.7486","volume":"166","author":"PK Epling-Burnette","year":"2001","unstructured":"Epling-Burnette PK, Zhong B, Bai F et al (2001) Cooperative Regulation of Mcl-1 by Janus Kinase\/STAT and phosphatidylinositol 3-Kinase contribute to Granulocyte-Macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol 166:7486\u20137495. https:\/\/doi.org\/10.4049\/jimmunol.166.12.7486","journal-title":"J Immunol"},{"key":"5579_CR90","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/mi.2013.102","volume":"7","author":"CD Lucas","year":"2014","unstructured":"Lucas CD, Dorward DA, Tait MA et al (2014) Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung. Mucosal Immunol 7:857\u2013868. https:\/\/doi.org\/10.1038\/mi.2013.102","journal-title":"Mucosal Immunol"},{"key":"5579_CR91","doi-asserted-by":"publisher","first-page":"2899271","DOI":"10.1155\/2023\/2899271","volume":"2023","author":"V Lannoy","year":"2023","unstructured":"Lannoy V, C\u00f4t\u00e9-Biron A, Asselin C, Rivard N (2023) TIRAP, TRAM, and toll-like receptors: the Untold Story. Mediators Inflamm 2023:2899271. https:\/\/doi.org\/10.1155\/2023\/2899271","journal-title":"Mediators Inflamm"},{"key":"5579_CR92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/35092578","volume":"413","author":"KA Fitzgerald","year":"2001","unstructured":"Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al (2001) Mal (MyD88-adapter-like) is required for toll-like receptor-4 signal transduction. Nature 413:78\u201383. https:\/\/doi.org\/10.1038\/35092578","journal-title":"Nature"},{"key":"5579_CR93","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1073\/pnas.0608100104","volume":"104","author":"SM Miggin","year":"2007","unstructured":"Miggin SM, P\u00e5lsson-McDermott E, Dunne A et al (2007) NF-\u03baB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1. Proc Natl Acad Sci USA 104:3372. https:\/\/doi.org\/10.1073\/pnas.0608100104","journal-title":"Proc Natl Acad Sci USA"},{"key":"5579_CR94","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.celrep.2015.05.035","volume":"11","author":"W Piao","year":"2015","unstructured":"Piao W, Shirey KA, Ru LW et al (2015) A decoy peptide that disrupts TIRAP recruitment to TLRs is protective in a murine model of Influenza. Cell Rep 11:1941\u20131952. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.035","journal-title":"Cell Rep"},{"key":"5579_CR95","doi-asserted-by":"publisher","first-page":"e107141","DOI":"10.1371\/journal.pone.0107141","volume":"9","author":"E Shevlin","year":"2014","unstructured":"Shevlin E, Miggin SM (2014) The TIR-Domain containing adaptor TRAM is required for TLR7 mediated RANTES Production. PLoS ONE 9:e107141. https:\/\/doi.org\/10.1371\/journal.pone.0107141","journal-title":"PLoS ONE"},{"key":"5579_CR96","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1038\/s41598-023-34211-x","volume":"13","author":"T Wongchang","year":"2023","unstructured":"Wongchang T, Pluangnooch P, Hongeng S et al (2023) Inhibition of DYRK1B suppresses inflammation in allergic contact dermatitis model and Th1\/Th17 immune response. Sci Rep 13:7058. https:\/\/doi.org\/10.1038\/s41598-023-34211-x","journal-title":"Sci Rep"},{"key":"5579_CR97","doi-asserted-by":"publisher","first-page":"926","DOI":"10.3389\/fimmu.2017.00926","volume":"8","author":"D Meley","year":"2017","unstructured":"Meley D, H\u00e9raud A, Gouilleux-Gruart V et al (2017) Tocilizumab contributes to the inflammatory status of mature dendritic cells through Interleukin-6 receptor subunits Modulation. Front Immunol 8:926. https:\/\/doi.org\/10.3389\/fimmu.2017.00926","journal-title":"Front Immunol"},{"key":"5579_CR98","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00018-015-2032-x","volume":"73","author":"AL Ashford","year":"2016","unstructured":"Ashford AL, Dunkley TPJ, Cockerill M et al (2016) Identification of DYRK1B as a substrate of ERK1\/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome. Cell Mol Life Sci 73:883\u2013900. https:\/\/doi.org\/10.1007\/s00018-015-2032-x","journal-title":"Cell Mol Life Sci"},{"key":"5579_CR99","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2867-13-2","volume":"13","author":"J Gao","year":"2013","unstructured":"Gao J, Zhao Y, Lv Y et al (2013) Mirk\/Dyrk1B mediates G0\/G1 to S phase cell cycle progression and cell survival involving MAPK\/ERK signaling in human cancer cells. Cancer Cell Int 13:2. https:\/\/doi.org\/10.1186\/1475-2867-13-2","journal-title":"Cancer Cell Int"},{"key":"5579_CR100","doi-asserted-by":"publisher","first-page":"41347","DOI":"10.1074\/jbc.M306780200","volume":"278","author":"X Deng","year":"2003","unstructured":"Deng X, Ewton DZ, Pawlikowski B et al (2003) Mirk\/dyrk1B is a rho-induced kinase active in skeletal muscle differentiation. J Biol Chem 278:41347\u201341354. https:\/\/doi.org\/10.1074\/jbc.M306780200","journal-title":"J Biol Chem"},{"key":"5579_CR101","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1038\/sj.onc.1203476","volume":"19","author":"J Bromberg","year":"2000","unstructured":"Bromberg J, Darnell JE (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468\u20132473. https:\/\/doi.org\/10.1038\/sj.onc.1203476","journal-title":"Oncogene"},{"key":"5579_CR102","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A et al (2014) Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14:736\u2013746. https:\/\/doi.org\/10.1038\/nrc3818","journal-title":"Nat Rev Cancer"},{"key":"5579_CR103","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/bfgp\/elt028","volume":"12","author":"AP Hutchins","year":"2013","unstructured":"Hutchins AP, Diez D, Miranda-Saavedra D (2013) The IL-10\/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genomics 12:489\u2013498. https:\/\/doi.org\/10.1093\/bfgp\/elt028","journal-title":"Brief Funct Genomics"},{"key":"5579_CR104","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00395-023-01003-3","volume":"118","author":"P Kleinbongard","year":"2023","unstructured":"Kleinbongard P (2023) Perspective: mitochondrial STAT3 in cardioprotection. Basic Res Cardiol 118:32. https:\/\/doi.org\/10.1007\/s00395-023-01003-3","journal-title":"Basic Res Cardiol"},{"key":"5579_CR105","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cei\/uxad007","volume":"212","author":"J Mackie","year":"2023","unstructured":"Mackie J, Ma CS, Tangye SG, Guerin A (2023) The ups and downs of STAT3 function: too much, too little and human immune dysregulation. Clin Exp Immunol 212:107\u2013116. https:\/\/doi.org\/10.1093\/cei\/uxad007","journal-title":"Clin Exp Immunol"},{"key":"5579_CR106","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1021\/acs.jmedchem.2c02068","volume":"66","author":"MF Lindberg","year":"2023","unstructured":"Lindberg MF, Deau E, Arfwedson J et al (2023) Comparative efficacy and selectivity of pharmacological inhibitors of DYRK and CLK Protein Kinases. J Med Chem 66:4106\u20134130. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c02068","journal-title":"J Med Chem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05579-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05579-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05579-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T09:49:20Z","timestamp":1740217760000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05579-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5579"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05579-y","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"12 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving mice were performed in accordance with ethical standards and were approved by the Hessian Animal Care and Use Committee (FU\/2064) (imiquimod-induced psoriasis mouse model) or by the Animal Welfare Commission of North Rhine-Westphalia (NRW) with the permission number Az 81-02.04.2022.A338 (CNV model). The Research Ethics Committee\/Institutional Review Board approved waiver W1\/21F\u00fc for the use of anonymized human material on 15 September 2021 (HUVEC isolation).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}